Experience

King & Wood Mallesons (PRC)

• China
• Legal Services
• 1 - 100 Employee

• Associate Lawyer

  • Dec 2018 - Present

  Licensed in PRC, 4-year practicing in domestic capital market area including IPO, M&A, etc. Experienced in conducting legal due diligence in varies industries under PRC law. IPO: Beijing-Shanghai High-speed Railway Co., Ltd. (SH.601816); Yunnan Shennong Agricultural Industry Group Co., Ltd. (SH.605296); Youyan Powder New Material Co., Ltd. (SH.688456, Sci-Tech Innovation Board); Shaanxi Tongli Heavy Industry Co., Ltd. (BJ.834599, Selected Layer of the New Third… Show more Licensed in PRC, 4-year practicing in domestic capital market area including IPO, M&A, etc. Experienced in conducting legal due diligence in varies industries under PRC law. IPO: Beijing-Shanghai High-speed Railway Co., Ltd. (SH.601816); Yunnan Shennong Agricultural Industry Group Co., Ltd. (SH.605296); Youyan Powder New Material Co., Ltd. (SH.688456, Sci-Tech Innovation Board); Shaanxi Tongli Heavy Industry Co., Ltd. (BJ.834599, Selected Layer of the New Third Board); Beijing Panther Medical Technology Co., Ltd. (H Shares, on progress); Beijing Huada Jiutian Technology Co., Ltd. (SZ.301269, GEM); Beijing Jiwei Spatial Information Co., Ltd. (Sci-Tech Innovation Board, on progress); Xi'an Nova Nebula Technology Co., Ltd. (GEM, registration stage); A pharmaceutical intermediate and API company in Beijing (Pre-IPO due diligence). Equity Investments: Beijing Panther Medical Technology Co., Ltd.’s acquisition of Suzhou Vicente Medical Robot Co., Ltd.’s equity; China Telecom Group Investment Co., Ltd.'s acquisition of Shanghai Detuo Information Technology Co., Ltd.'s equity; Wuhan Geological Resources and Environment Industrial Technology Research Institute Co., Ltd.’s acquisition of equity and investment on Wuhan Zhongji Hydrogen Energy Development Co., Ltd.; Beijing Yicheng Goldwind Green Energy Co., Ltd.’s acquisition of the two new energy companies. Refinancing of listed companies: Northeast Pharmaceutical Group Co., Ltd. (SZ.000597) non-public offering of stock. Major asset restructuring: The major asset restructuring of the former FAW Car Co., Ltd. (FAW Jiefang SZ.000800) . Show less Licensed in PRC, 4-year practicing in domestic capital market area including IPO, M&A, etc. Experienced in conducting legal due diligence in varies industries under PRC law. IPO: Beijing-Shanghai High-speed Railway Co., Ltd. (SH.601816); Yunnan Shennong Agricultural Industry Group Co., Ltd. (SH.605296); Youyan Powder New Material Co., Ltd. (SH.688456, Sci-Tech Innovation Board); Shaanxi Tongli Heavy Industry Co., Ltd. (BJ.834599, Selected Layer of the New Third… Show more Licensed in PRC, 4-year practicing in domestic capital market area including IPO, M&A, etc. Experienced in conducting legal due diligence in varies industries under PRC law. IPO: Beijing-Shanghai High-speed Railway Co., Ltd. (SH.601816); Yunnan Shennong Agricultural Industry Group Co., Ltd. (SH.605296); Youyan Powder New Material Co., Ltd. (SH.688456, Sci-Tech Innovation Board); Shaanxi Tongli Heavy Industry Co., Ltd. (BJ.834599, Selected Layer of the New Third Board); Beijing Panther Medical Technology Co., Ltd. (H Shares, on progress); Beijing Huada Jiutian Technology Co., Ltd. (SZ.301269, GEM); Beijing Jiwei Spatial Information Co., Ltd. (Sci-Tech Innovation Board, on progress); Xi'an Nova Nebula Technology Co., Ltd. (GEM, registration stage); A pharmaceutical intermediate and API company in Beijing (Pre-IPO due diligence). Equity Investments: Beijing Panther Medical Technology Co., Ltd.’s acquisition of Suzhou Vicente Medical Robot Co., Ltd.’s equity; China Telecom Group Investment Co., Ltd.'s acquisition of Shanghai Detuo Information Technology Co., Ltd.'s equity; Wuhan Geological Resources and Environment Industrial Technology Research Institute Co., Ltd.’s acquisition of equity and investment on Wuhan Zhongji Hydrogen Energy Development Co., Ltd.; Beijing Yicheng Goldwind Green Energy Co., Ltd.’s acquisition of the two new energy companies. Refinancing of listed companies: Northeast Pharmaceutical Group Co., Ltd. (SZ.000597) non-public offering of stock. Major asset restructuring: The major asset restructuring of the former FAW Car Co., Ltd. (FAW Jiefang SZ.000800) . Show less